Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05759923
Title First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Molecure S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL

Facility Status City State Zip Country Details
Site RECRUITING Bydgoszcz Kujawsko-pomorskie 85796 Poland Details
Site RECRUITING Otwock Mazowieckie 05-400 Poland Details
SIte RECRUITING Warsaw Mazowieckie 01748 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field